Bausch Health Companies Inc.
BHC
$4.94
-$0.12-2.28%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.49% | 7.05% | 5.25% | 4.60% | 6.13% |
| Total Other Revenue | -9.68% | -14.29% | 8.33% | 33.33% | 19.23% |
| Total Revenue | 9.26% | 6.81% | 5.29% | 4.92% | 6.27% |
| Cost of Revenue | 9.77% | 7.76% | 6.26% | 9.53% | 3.12% |
| Gross Profit | 9.06% | 6.45% | 4.87% | 2.97% | 7.57% |
| SG&A Expenses | 8.24% | -6.47% | 7.45% | 9.25% | 6.69% |
| Depreciation & Amortization | -8.88% | -7.66% | -5.19% | -6.57% | -8.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.76% | -0.10% | 4.86% | 5.83% | 3.21% |
| Operating Income | 20.77% | 31.80% | 7.28% | -0.67% | 17.75% |
| Income Before Tax | -73.21% | 1,138.10% | 191.67% | 31.88% | 3,085.71% |
| Income Tax Expenses | 43.24% | -47.89% | -75.51% | 387.50% | 177.50% |
| Earnings from Continuing Operations | -205.10% | 296.74% | 12,900.00% | -11.69% | 308.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -80.00% | -128.57% | 81.82% | 115.38% | -162.50% |
| Net Income | -220.43% | 310.59% | 1,380.00% | 9.38% | 338.46% |
| EBIT | 20.77% | 31.80% | 7.28% | -0.67% | 17.75% |
| EBITDA | 11.84% | 18.13% | 2.69% | -2.75% | 8.13% |
| EPS Basic | -220.00% | 306.63% | 1,366.91% | 10.09% | 327.27% |
| Normalized Basic EPS | 27.73% | 40.57% | -92.33% | 145.30% | 52.67% |
| EPS Diluted | -221.46% | 306.63% | 1,366.91% | 10.09% | 324.55% |
| Normalized Diluted EPS | 27.73% | 40.57% | -92.35% | 145.30% | 52.67% |
| Average Basic Shares Outstanding | 0.36% | 1.93% | 0.82% | 0.76% | 4.92% |
| Average Diluted Shares Outstanding | 0.36% | 1.93% | 0.78% | 0.76% | 4.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |